Perceptive Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-75,898
| Closed | -$12.9M | – | 131 |
|
|
2018
Q2 | $12.9M | Sell |
75,898
-76,000
| -50% | -$12.9M | 0.34% | 55 |
|
|
2018
Q1 | $24.8M | Buy |
151,898
+13,272
| +10% | +$2.16M | 0.69% | 34 |
|
|
2017
Q4 | $20.8M | Hold |
138,626
| – | – | 0.69% | 38 |
|
|
2017
Q3 | $21.1M | Sell |
138,626
-138,726
| -50% | -$21.1M | 0.81% | 30 |
|
|
2017
Q2 | $35.7M | Sell |
277,352
-16,157
| -6% | -$2.08M | 1.8% | 15 |
|
|
2017
Q1 | $32.1M | Buy |
293,509
+208,000
| +243% | +$22.7M | 1.83% | 17 |
|
|
2016
Q4 | $6.3M | Sell |
85,509
-21,491
| -20% | -$1.58M | 0.45% | 52 |
|
|
2016
Q3 | $9.33M | Sell |
107,000
-23,000
| -18% | -$2.01M | 0.6% | 41 |
|
|
2016
Q2 | $11.2M | Sell |
130,000
-30,000
| -19% | -$2.58M | 0.78% | 25 |
|
|
2016
Q1 | $12.7M | Buy |
160,000
+50,000
| +45% | +$3.97M | 1.12% | 22 |
|
|
2015
Q4 | $13.8M | Buy |
+110,000
| New | +$13.8M | 1.02% | 23 |
|
|
2015
Q1 | – | Sell |
-110,000
| Closed | -$13.1M | – | 166 |
|
|
2014
Q4 | $13.1M | Sell |
110,000
-130,142
| -54% | -$15.5M | 1.1% | 24 |
|
|
2014
Q3 | $27M | Sell |
240,142
-230,000
| -49% | -$25.8M | 2.73% | 10 |
|
|
2014
Q2 | $44.5M | Sell |
470,142
-111,586
| -19% | -$10.6M | 4.37% | 4 |
|
|
2014
Q1 | $41.1M | Sell |
581,728
-230,000
| -28% | -$16.3M | 4.32% | 4 |
|
|
2013
Q4 | $60.3M | Buy |
811,728
+359,633
| +80% | +$26.7M | 7.24% | 4 |
|
|
2013
Q3 | $34.3M | Buy |
452,095
+195,548
| +76% | +$14.8M | 2.78% | 10 |
|
|
2013
Q2 | $20.5M | Buy |
+256,547
| New | +$20.5M | 2.07% | 11 |
|